Spinosin Protects Neuro-2a/APP695 Cells from Oxidative Stress Damage by Inactivating P38

Overview

Journal J Tradit Chin Med

Date 2023 Sep 8

PMID 37679974

Authors

Zhang Xiaoying

Wang Ruixuan

Wang Yiqing

X U Fanxing

Yan Tingxu

W U Bo

Zhang Ming

Jia Ying

Affiliations

Soon will be listed here.

Abstract

Objective: To explore the protective mechanism of spinosin (SPI) on Alzheimer's disease (AD) model cells, Neuro-2a/APP695 (N2a/APP695), against HO-induced oxidative stress damage, to reflect the influence of oxidative stress on the development of AD, and to provide a valuable basis for the research and development of therapeutic drug for AD.

Methods: N2a/APP695 cells were exposed to HO and then treated with spinosin. Firstly, the secretion level of amyloid β (Aβ) and the production of malondialdehyde (MDA) and lactate dehydrogenase (LDH) were detected by enzyme linked immunosorbent assay kits. Secondly, the oligomerization degree of Aβ was performed by Thioflavin T staining. Thirdly, the expression levels of p-Tau (Ser199/202/396), synaptophysin (SYP), postsynaptic density protein 95 (PSD95), and mitogen-activated protein kinase (MAPK) family-related proteins were detected by Western blot analysis. In addition, FITC-labeled phalloidin was used in cytoskeleton staining to reflect synaptic function.

Results: This study showed that HO stimulated N2a/APP695 cells to produce excessive MDA and LDH and secrete a large amount of Aβ, promoted the aggregation of Aβ, induced Tau protein hyperphosphorylation, and led to synaptic dysfunction. Spinosin reversed these changes caused by HO by inactivating p38, which was verified by treatment with the p38 inhibitor BIRB796.

Conclusion: Spinosin protects N2a/APP695 cells from oxidative stress damage caused by HO through inactivating p38.

References

Xu F, Zhang X, Wang J, Li X, He B, Xiao F . Spinosin protects N2a cells from H O -induced neurotoxicity through inactivation of p38MAPK. J Pharm Pharmacol. 2020; 72(11):1607-1614. DOI: 10.1111/jphp.13334. View

Xu F, He B, Xiao F, Yan T, Bi K, Jia Y . Neuroprotective Effects of Spinosin on Recovery of Learning and Memory in a Mouse Model of Alzheimer's Disease. Biomol Ther (Seoul). 2018; 27(1):71-77. PMC: 6319550. DOI: 10.4062/biomolther.2018.051. View

Karthick C, Nithiyanandan S, Essa M, Guillemin G, Jayachandran S, Anusuyadevi M . Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease. Neurol Res. 2018; 41(2):139-150. DOI: 10.1080/01616412.2018.1544745. View

Pooler A, Noble W, Hanger D . A role for tau at the synapse in Alzheimer's disease pathogenesis. Neuropharmacology. 2013; 76 Pt A:1-8. DOI: 10.1016/j.neuropharm.2013.09.018. View

Michalska P, Mayo P, Fernandez-Mendivil C, Tenti G, Duarte P, Buendia I . Antioxidant, Anti-inflammatory and Neuroprotective Profiles of Novel 1,4-Dihydropyridine Derivatives for the Treatment of Alzheimer's Disease. Antioxidants (Basel). 2020; 9(8). PMC: 7463999. DOI: 10.3390/antiox9080650. View

Teixeira J, de Castro A, Soares F, da Cunha E, Ramalho T . Future Therapeutic Perspectives into the Alzheimer's Disease Targeting the Oxidative Stress Hypothesis. Molecules. 2019; 24(23). PMC: 6930470. DOI: 10.3390/molecules24234410. View

Ennerfelt H, Lukens J . The role of innate immunity in Alzheimer's disease. Immunol Rev. 2020; 297(1):225-246. PMC: 7783860. DOI: 10.1111/imr.12896. View

Tu S, Okamoto S, Lipton S, Xu H . Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease. Mol Neurodegener. 2014; 9:48. PMC: 4237769. DOI: 10.1186/1750-1326-9-48. View

Qi Y, Guo L, Jiang Y, Shi Y, Sui H, Zhao L . Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles. Drug Deliv. 2020; 27(1):745-755. PMC: 7269046. DOI: 10.1080/10717544.2020.1762262. View

10.

Tang Y, Min Z, Xiang X, Liu L, Ma Y, Zhu B . Estrogen-related receptor alpha is involved in Alzheimer's disease-like pathology. Exp Neurol. 2018; 305:89-96. DOI: 10.1016/j.expneurol.2018.04.003. View

11.

Duan Q, Si E . MicroRNA-25 aggravates Aβ1-42-induced hippocampal neuron injury in Alzheimer's disease by downregulating KLF2 via the Nrf2 signaling pathway in a mouse model. J Cell Biochem. 2019; 120(9):15891-15905. DOI: 10.1002/jcb.28861. View

12.

Su B, Wang X, Lee H, Tabaton M, Perry G, Smith M . Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells. Neurosci Lett. 2009; 468(3):267-71. DOI: 10.1016/j.neulet.2009.11.010. View

13.

Yao E, Tang Y, Liu X, Wang M . TPPU protects tau from HO-induced hyperphosphorylation in HEK293/tau cells by regulating PI3K/AKT/GSK-3β pathway. J Huazhong Univ Sci Technolog Med Sci. 2016; 36(6):785-790. DOI: 10.1007/s11596-016-1662-z. View

14.

Fang X, Hao J, Zhou H, Zhu L, Wang J, Song F . Pharmacological studies on the sedative-hypnotic effect of Semen Ziziphi spinosae (Suanzaoren) and Radix et Rhizoma Salviae miltiorrhizae (Danshen) extracts and the synergistic effect of their combinations. Phytomedicine. 2009; 17(1):75-80. DOI: 10.1016/j.phymed.2009.07.004. View

15.

Xiao L, Liao F, Ide R, Horie T, Fan Y, Saiki C . Enzyme-digested (E'jiao) prevents hydrogen peroxide-induced cell death and accelerates amyloid beta clearance in neuronal-like PC12 cells. Neural Regen Res. 2020; 15(12):2270-2272. PMC: 7749479. DOI: 10.4103/1673-5374.285000. View

16.

Prasad K . AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease. Mol Cell Biochem. 2019; 459(1-2):95-112. DOI: 10.1007/s11010-019-03553-4. View

17.

Schnoder L, Hao W, Qin Y, Liu S, Tomic I, Liu X . Deficiency of Neuronal p38α MAPK Attenuates Amyloid Pathology in Alzheimer Disease Mouse and Cell Models through Facilitating Lysosomal Degradation of BACE1. J Biol Chem. 2015; 291(5):2067-79. PMC: 4732195. DOI: 10.1074/jbc.M115.695916. View

18.

Hanger D, Anderton B, Noble W . Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med. 2009; 15(3):112-9. DOI: 10.1016/j.molmed.2009.01.003. View

19.

Su J, Cummings B, Cotman C . Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. Neuroreport. 1994; 5(17):2358-62. DOI: 10.1097/00001756-199411000-00037. View

20.

Arias E, Gallego-Sandin S, Villarroya M, Garcia A, Lopez M . Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. J Pharmacol Exp Ther. 2005; 315(3):1346-53. DOI: 10.1124/jpet.105.090365. View